United Nations to shut 150 clinics in Africa's most populous country amid aid cuts
The WFP will close half of its clinics in Nigeria's northeast due to insufficient donor support.
Over 300,000 children under two face losing access to lifesaving nutrition treatment.
The WFP urgently appeals for $130 million in funding to support its programs through 2025.
The United Nations World Food Programme (WFP) will shut half of its clinics in Nigeria's conflict-hit northeast this month, as dwindling donor support forces the agency to scale back humanitarian operations.
With more than 150 WFP-supported nutrition clinics in Borno and Yobe states set to close if funding is not renewed, over 300,000 children under the age of two will lose access to potential lifesaving treatment.
'This is no longer just a humanitarian crisis,' said WFP Country Director David Stevenson. ' It's a growing threat to regional stability as families pushed beyond their limits are left with nowhere to turn.'
Despite urgent appeals for $130 million to sustain its programs through 2025, the WFP said it has received no funding to continue food and nutrition assistance for 1.3 million people.
Nigeria is facing a deepening food crisis, with a record 31 million people experiencing food insecurity, according to the UN. The situation is particularly dire in the insurgency-ravaged northeast, where nearly 20% of the population is grappling with acute hunger.
Foreign aid freeze hits
In recent months, the United Nations World Food Programme (WFP) has been forced to scale back food rations to Nigeria as U.S. funding dries up. The sharp cuts are a direct consequence of President Donald Trump's renewed push to slash foreign aid under his 'America First' agenda.
An executive order signed on January 20, 2025, imposed a 90-day freeze on all U.S. foreign development assistance, triggering an immediate halt to countless aid programs worldwide.
On January 20, 2025, an executive order put a 90-day hold on all US foreign development assistance, leading to the widespread suspension of aid programs. Till today, the United States still insists on drastically reducing the amount of aid sent to other countries.
The Nigerian Ministry of Health has not outlined how it plans to address the impending gap. This year, the federal government allocated a mere $326,000 to combat malnutrition and stunting in the most affected states, a figure widely seen as grossly inadequate given the scale of the crisis.
Humanitarian agencies across Africa are reeling from a sharp decline in foreign aid, exacerbated by the US under President Donald Trump, which has been slashing overseas assistance.
European nations, too, are redirecting resources inward to meet domestic priorities, leaving countries like Nigeria vulnerable.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
US axes mRNA vaccine contracts, casting safety doubts
President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives. The announcement, made by Health Secretary Robert F. Kennedy Jr., marks his latest effort to weave vaccine skepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine -- a move the company itself disclosed in May -- as well as numerous other programs, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly $500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunization, has overseen a major overhaul of US health policy -- firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed -- a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times." ia/jgc
Yahoo
2 hours ago
- Yahoo
SNAP Rules Tighten To Restrict Junk Food, Sodas: Advocates Praise Online Access Boost
As top federal officials gathered in the capital on Monday to promote a new push to restrict soda and junk food from SNAP purchases, a Texas food access expert was hundreds of miles away, explaining how recent changes to the same program have expanded healthy options for people experiencing poverty. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and Agriculture Secretary Brooke Rollins hosted a joint press event in Washington as part of President Donald Trump's 'Make America Healthy Again' initiative, unveiling new SNAP waivers and calling for broader federal restrictions on sugary drinks, as previously covered by The Dallas Express. 'If you want to buy a sugary soda — the U.S. taxpayer should not pay for it,' Kennedy said. 'The U.S. taxpayer should not be paying to feed kids foods, the poorest kids in the country, that will give them diabetes.' The Breakdown: Robert F. Kennedy Jr. wants to ban SNAP users from buying soda nationally. New waivers approved for Florida, Texas, and four other states on Monday. Kennedy and Rollins say the goal is to improve health and reduce Medicaid costs. Meanwhile in Texas, advocates say online SNAP expansion is helping. The tension underscores a national debate on food access vs. government regulation. Speaking at the Great American Farmers Market in Washington, Kennedy said sugary drinks and candies make up nearly 17% of current SNAP expenditures and argued the government 'pays twice' — first through SNAP benefits, then through the downstream cost of chronic diseases. Rollins echoed that message. 'One way … is disallowing taxpayer-funded benefits to purchase unhealthy items like soda, candy, and other junk food,' Rollins explained. 'SNAP is a supplemental nutrition program meant to provide food benefits to low-income families … essential to health and well-being.' Rollins signed new waivers on Monday for Florida, West Virginia, Oklahoma, Texas, Louisiana, and Colorado. These come in addition to previous waivers in Arkansas, Utah, Idaho, Indiana, Iowa, and Nebraska, which restrict soda and candy in various forms starting in 2026. In her remarks, Rollins framed the effort as both fiscally responsible and morally urgent, citing statistics about obesity, diabetes, and mental health challenges in children. 'Over 75% of American youth between the ages of 17 and 24 are ineligible for military service because of obesity, poor physical fitness, or mental health challenges,' explained Rollins. Yet some believe Kennedy and Rollins' work to limit soda to promote health is misguided. 'The problem with soda consumption in the U.S. is not SNAP users,' Hilary Seligman, a public health researcher at the University of California, San Francisco, previously told The New York Times. 'If you try to solve this problem using SNAP as a lever, so only SNAP people are impacted by it, what we're likely to do is just increase stigma for people who are trying to make ends meet.' Some former Obama and Biden officials agree with Seligman. 'It doesn't pay for everyone's food for the entire month,' former Agriculture Secretary Tom Vilsack told NYT. 'So what would prevent people from spending their own money on sugary drinks or soda? The notion of restricting it for nutritional purposes really isn't a valid reason.' While the Trump administration officials were speaking about SNAP, Celebrindal Roberts, procurement and logistics manager for Farmshare Austin, was addressing attendees at the Southern Family Farmers and Food Systems Conference, held at Texas State University. Roberts offered a more local perspective on SNAP, noting that her nonprofit has accepted SNAP since 2016 and began accepting online SNAP in October 2024. She described online payments as a 'game-changer,' explaining that they reduce delivery and administrative costs, allow for unattended home delivery, and increase access to healthy food for people in areas with limited grocery infrastructure. 'You sell more food with Double Up Food Bucks and SNAP online,' Roberts said. Double Up Food Bucks (DUFB) is a program that allows SNAP users to double the value of their benefits when buying fruits and vegetables. Roberts praised the program but noted it currently does not cover canned goods or honey, which limits its reach in some food-insecure households. Roberts also said the online system has improved safety for delivery drivers and staff by reducing the need for carrying cash. Refunds from canceled or delayed orders are now returned directly to customers' SNAP cards, making the entire process more seamless for users and vendors alike. Farmshare Austin's 13-acre certified organic farm supplies a mobile market, home delivery program, and postpartum food access initiative. The group serves 25 ZIP codes in the Eastern Crescent of Austin and Travis County. While battles continue to rage about the prudence of various changes and innovations with SNAP, Kennedy insists that change is long overdue. 'For 20 years Democrats and Republicans have been talking about this on Capitol Hill,' he said. 'We have no problem with [soda consumption] … taxpayer dollars should not be funding these injuries to our children,' Kennedy said. Despite previous legal hurdles faced by states seeking to restrict SNAP purchases, Rollins and Kennedy say the administration is now working to bypass congressional gridlock and encourage all governors to submit waivers. It remains to be seen whether the growing push for restrictions will be met with resistance from health equity advocates, grocers, or SNAP recipients themselves. But both Kennedy and Rollins framed the reforms as a defining front in Trump's broader push for 'nutrition, not just food assistance.' Solve the daily Crossword
Fox News
6 hours ago
- Fox News
Trump's quest to reduce drug prices is heating up. But will he be able to do it?
President Donald Trump is ramping up the heat on pharmaceutical companies, urging them in letters sent Thursday to cut down drug prices in accordance with an executive order he signed in May. But Trump has limited authority to actually force drug companies to adjust prices, according to experts, and his effort equates to price control. As a result, utilizing public pressure through these letters may be one tool he's employing to get companies to comply, according to Benedic Ippolito, a senior fellow in economic policy studies at the conservative-leaning American Enterprise Institute think tank. "One of the big questions has been just how much can the administration realistically pressure these drugmakers to do something that is at least nominally voluntary," Ippolito told Fox News Digital Monday. Drug prices have dramatically climbed in recent years. Prescription drug prices increased more than 15% from January 2022 and January 2023, reaching an average of $590 per drug product, according to the Department of Health and Human Services. Of the 4,200 prescription drugs included on that list, 46% of the price increases exceeded the rate of inflation. Trump's original executive order signed in May directs the Department of Health and Human Services to establish price targets for pharmaceutical manufacturers. Failure to comply will prompt the Justice Department and the Federal Trade Commission to "undertake enforcement action against any anti-competitive practices," along with other consequences. Additionally, Trump introduced plans to launch "most favored nations drug pricing." "The principle is simple – whatever the lowest price paid for a drug in other developed countries, that is the price that Americans will pay," Trump said at the White House in May upon signing the order. "Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%." "We're going to equalize," Trump said. "We're all going to pay the same. We're going to pay what Europe pays." However, Ippolito said Trump's ability to actually lower the cost of drugs will be dependent on the administration's ability to present drug companies with a "credible threat" to pressure them into submission. "The administration, realistically, does not have a ton of leverage to force drugmakers to change their behavior," Ippolito said. "I think that's the practical reality." Additionally, Ippolito said Congress has greater authority to establish new laws that would have "profound implications for drug markets." But Trump's views on the issue may not attract support from even members of his own party, he said. "Congressional Republicans are generally more hesitant to do bold things on drug pricing, and the administration, the president, seems to have quite different views," Ippolito said. "And so I think he probably looks at Congress and sees some people who may not share his vision on this particular issue." Michael Cannon, director of health policy studies at the Washington-based libertarian-leaning Cato Institute think tank, said the effort amounts to price controls since the executive order isn't limited to government programs – it applies to the free market and private sector as well. "This is government price controls," Cannon told Fox News Digital Monday. "It is even worse than government price controls, because it is government price controls without Congress' permission." Price control occurs when the government steps in to impose limits on how much one can charge for various goods or services in the free market. While price controls may lower costs for some consumers, they have largely been ineffective in American history. For example, President Richard Nixon implemented price controls in the 1970s in an attempt to fix wages and other costs – which backfired and resulted in the gas crisis and other shortages across the country. Meanwhile, Cannon said there are plenty of other avenues that could lead to reduced drug prices, including reforms to Medicaid, Medicare and the tax code. But all those options would involve the legislative branch. "Those things require Congress, for the most part, and it's hard to get anything through Congress that would reduce wasteful spending in the health sector," Cannon said. The White House sent letters to the following drug companies Thursday, advocating for lower drug prices: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron and Sanofi.
